Sustained release of microcrystalline peptide suspensions

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

11450293

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to a microcrystalline aqueous suspension of a peptide salt selected from the group consisting of Ac--D--Nal--D--Cpa--D--Pal--Ser--Tyr--D--Hci--Leu--Ilys--Pro--D--Ala--NH.-sub.2trifluoroacetate and Ac--D--Nal--D--Cpa--D--Pal--Ser--Tyr--D--Hci--Leu--Ilys--Pro--D--Ala--NH.-sub.2 sulfate. The invention also relates to methods of preparing the suspension, lyophilized compositions formed from the suspensions, and sustained release formulations that include the suspensions.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ARDANA BIOSCIENCE LIMITEDNot Provided

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Boutignon, Francois Ermont, FR 14 130
Deghenghi, Romano St. Cergue, CH 32 724

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation